Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by R. H. Loke
Randomised Controlled Trial of Interferon Alfa (Lymphoblastoid Interferon) in Chronic Non-A Non-B Hepatitis.
BMJ
Related publications
Low Dose Interferon Alfa-2b for Chronic Hepatitis B in Asian Countries.
Gut
Gastroenterology
Efficacy of Consensus Interferon in Treatment of HbeAg-positive Chronic Hepatitis B: A Multicentre, Randomized Controlled Trial
Virology Journal
Virology
Infectious Diseases
Editorial: The Durability of Seroconversion of Hepatitis B E Antigen in the Treatment of Chronic Hepatitis B With PEG-interferon Alfa-2a
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Impact of Pegylated Interferon-Alfa-2a on Perforin Level in Patients With Chronic Hepatitis B; Preliminary Study
Hepatitis Monthly
Hepatology
Infectious Diseases
A Randomised Placebo Controlled Trial of Pegylated Interferon in Active Ulcerative Colitis
Gut
Gastroenterology
Interferon and Lamivudine vs. Interferon for Hepatitis B E Antigen-Positive Hepatitis B Treatment: Meta-Analysis of Randomized Controlled Trials
Liver International
Hepatology
Lack of Efficacy of Low Dose Oral Interferon Alfa in Symptomatic HIV-1 Infection: A Randomised, Double Blind, Placebo Controlled Trial
Sexually Transmitted Infections
Dermatology
Infectious Diseases
A Limit of Current Interferon Therapy for Chronic Hepatitis Type B.
Acta Hepatologica Japonica
Hepatology
Treatment of Chronic Hepatitis C With Recombinant Interferon Alfa-2b for Nine Months.
Gut
Gastroenterology
